Hypertension

N.6A. Hypertension

1. Management of hypertension in patients with CKD Georgios Hatzivasiliou

2. Resistant hypertension Vasileios Raptis

3. Use of diuretics in CKD: benefits and risks Eleni Intzevidou

4. Hypertension in dialysis Antonios Zagorianakos

Διαλειμα - Καφές

N.5A. Changing the status quo in CKD

1. SGLT2 inhibitors: what's new? Dimitrios Vlahakos
2. The place of GLP-1 agonists in clinical practice Petros Kalogeropoulos

3. The place of MRAs in clinical practice Konstantinos Psounis

N.4A. IgA nephropathy

1. The role of B cells and BAFF/APRIL Dimitrios Bakoulis

2. New and emerging therapies in IgA nephropathy Panagiotis Kompotiatis

3. How should I manage the patient with IgA nephropathy Maria Stangou

N.3A. Cardiovascular morbidity in CKD

1. Treatment on hyperlipidaemia: what's new? Ioannis Droulias

2. HIF inhibitors: their place in clinical practice Athena Gompou

3. Update in the management of hyperkalaemia Evdokia Efthymiou

N.3A. Cardiovascular morbidity in CKD

1. Treatment on hyperlipidaemia: what's new? Ioannis Droulias

2. HIF inhibitors: their place in clinical practice Athena Gompou

3. Update in the management of hyperkalaemia Evdokia Efthymiou